These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1026256)

  • 21. Effect of N,N-dimethyltryptamine and D-lysergic acid diethylamide on the release of 5-hydroxyindoles in rat forebrain.
    Randić M; Padjen A
    Nature; 1971 Apr; 230(5295):532-3. PubMed ID: 4927758
    [No Abstract]   [Full Text] [Related]  

  • 22. Lysergic acid diethylamide (LSD 25). XXXX. Effect of pH on transport of methysergide and LSD 25 across gill membrane.
    Gettner HH; Carone PA; Abramson HA
    J Psychol; 1973 May; 84(1st Half):111-8. PubMed ID: 4705726
    [No Abstract]   [Full Text] [Related]  

  • 23. [Action of LSD-25 on the serontoninergic system of the rat brain modified by administration of 5-hydroxytryptophan].
    Torre M; Bogetto F; Torre E
    Minerva Psichiatr; 1981; 22(3):163-4. PubMed ID: 6975868
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA
    Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
    Westkaemper RB; Glennon RA
    NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain.
    Tonge SR; Leonard BE
    Life Sci; 1969 Aug; 8(15):805-14. PubMed ID: 5807313
    [No Abstract]   [Full Text] [Related]  

  • 27. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS; Drust EG; Damiano BP; Connor JD
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract]   [Full Text] [Related]  

  • 28. [Autoradiographic studies on the possibility of influencing 3H-leucine incorporation rates in different areas of rat brain by LSD (author's transl)].
    Gatzke HD
    Arzneimittelforschung; 1977 Jul; 27(7):1399-403. PubMed ID: 578461
    [No Abstract]   [Full Text] [Related]  

  • 29. An electrographic study of d-lysergic acid diethylamide and nine congeners.
    Schweigerdt AK; Stewart AH; Himwich HE
    J Pharmacol Exp Ther; 1966 Mar; 151(3):353-9. PubMed ID: 5938474
    [No Abstract]   [Full Text] [Related]  

  • 30. The relation between cerebral serotonin levels and conditioned behaviour in the rat following the administration of LSD-25 and UML.
    Torre M; Torre E; Bogetto F
    Psychopharmacologia; 1975; 41(3):245-7. PubMed ID: 1153613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
    Appel JB; Cunningham KA
    Psychopharmacol Bull; 1986; 22(3):959-67. PubMed ID: 3797596
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
    Pieri L; Keller HH; Burkard W; Da Prada M
    Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
    [No Abstract]   [Full Text] [Related]  

  • 33. p,p'-DDT-induced alterations in brain serotonin metabolism.
    Chung Hwang E; Van Woert MH
    Neurotoxicology; 1981 Dec; 2(4):649-57. PubMed ID: 6176920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The drug experience as a biological problem].
    Stille G
    Schweiz Med Wochenschr; 1971 Sep; 101(35):1257-69. PubMed ID: 4947024
    [No Abstract]   [Full Text] [Related]  

  • 36. d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex.
    Reissig CJ; Rabin RA; Winter JC; Dlugos CA
    Eur J Pharmacol; 2008 Mar; 583(1):40-7. PubMed ID: 18262520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
    Ziegler MG; Lovell RA; Freedman DX
    Biochem Pharmacol; 1973 Sep; 22(17):2183-93. PubMed ID: 4270151
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J; Pawlowski L; Sarnek J
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract]   [Full Text] [Related]  

  • 39. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological evidence for the existence of multiple functional pools of brain serotonin: analysis of brain perfusate from conscious rats.
    Kleven MS; Dwoskin LP; Sparber SB
    J Neurochem; 1983 Oct; 41(4):1143-9. PubMed ID: 6194257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.